CTTHCTT Pharmaceutical Holdings, Inc.

About CTT Pharmaceutical Holdings, Inc. (CTTH)

CTT Pharmaceutical Holdings, Inc. (CTTH) is a Drug Manufacturers - Specialty & Generic company headquartered in Tampa, FL, United States whose shares trade over-the-counter on the OTCQB tier.

CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in major markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the US, Canada, Europe and many other countries across the world.

Products and services

Patented Dissolvable Strips

CTTH key facts

Ticker symbol

CTTH

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Tampa, FL, United States

Country of incorporation

US

Year of incorporation

1996

Employees

1

Estimated market cap

$3.71M (as of Apr 10, 2025)

Shares outstanding

57,127,232

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

CTT Pharmaceutical Holdings, Inc. leadership

• Ryan Khouri — CEO
• Michael A Littman — Securities Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with C